KLK3 and prostate cancer: Less invasive diagnostic testing based on elevated levels of prostate-specific antigen (PSA) can identify up to 60% of cases of early prostate cancer, although the test gives false negative results in approximately 30% of patients because of its relatively low specificity 11, 12.